Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,430 | -15,983 | -9,540 | -5,005 | -18,550 |
| Depreciation Amortization | 670 | 509 | 339 | 170 | 670 |
| Accounts payable and accrued liabilities | -317 | -271 | -45 | -174 | 198 |
| Other Working Capital | -1,080 | -902 | -791 | -678 | 520 |
| Other Operating Activity | 2,957 | 3,389 | 550 | 1,442 | 3,432 |
| Operating Cash Flow | $-17,200 | $-13,258 | $-9,487 | $-4,246 | $-13,730 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | -6 | -6 | N/A | 0 |
| Investing Cash Flow | $-6 | $-6 | $-6 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 16,383 | 15,990 | 15,797 | 8,560 | 9,672 |
| Other Financing Activity | 437 | 0 | 0 | 0 | 8,908 |
| Financing Cash Flow | $16,820 | $15,990 | $15,797 | $8,560 | $18,580 |
| Beginning Cash Position | 8,080 | 8,086 | 8,086 | 8,086 | 3,230 |
| End Cash Position | 7,700 | 10,813 | 14,390 | 12,401 | 8,080 |
| Net Cash Flow | $-380 | $2,726 | $6,304 | $4,314 | $4,840 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,200 | -13,258 | -9,487 | -4,246 | -13,730 |
| Capital Expenditure | -6 | -6 | -6 | N/A | N/A |
| Free Cash Flow | -17,206 | -13,264 | -9,493 | -4,246 | -13,730 |